You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】恆指再彈500點、重上十天線 平保業績前好倉續有追捧 恆指牛69485 熊55685/ 平保購12998 牛60008/ 美團牛69514 熊59823
阿思達克 02-02 10:38
受科技股造好帶動,美股隔晚高收。道指收報30211點,升229點(或0.76%);納指升逾2.5%。恆指昨收報28892點,升609點(或2.2%),重上20天線並結束四連跌走勢。今早曾再升逾500點,高見29400點以上,收復10天線。恆指好倉(牛證及認購權證)昨淨流出逾7600萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾1.4億元,反映投資者預期大市上漲過後將回軟。昨日恆指牛證街貨重貨區為收回價27800至27899點,而熊證街貨重貨區為收回價29500至29599點。

美團(03690)經過近日回落整固,昨曾發力飆逾一成,高見392.4元,重返各移動平均線之上,全日收升9.89%於391元,是升幅最大藍籌。有券商上調美團目標價,指集團在雜貨及電商零售業務快速增長,潛在市場範圍未來增長可以加快。另有券商料美團上季外賣業務收入可按年增長34%,較去年第三季的33%增長輕微加快。美團今早漲近3%,高位重上407元,跟早前創下的上市高位407.6元只一步之遙。昨有逾22億元北水淨流入美團。輪證資金流方面,逾4900萬元淨流出其好倉,淡倉同日則有逾3100萬元淨流入。

平保(02318)將於明日公佈去年度業績,有券商料集團2020年新業務價值同比下降30%,但2021年有望回升14%。股份上日低見90元的逾兩個月低位後獲承接,收市倒升0.05元,報91.35元,結束四日跌勢,但仍受制於短期下降軌。平保今早曾升逾1%,重上92.7元,不過其後逆市轉跌,考驗91元的支持力。昨有逾1700萬元淨流入其好倉,淡倉同日則有逾280萬元淨流出,今早即市資金續買入其好倉。

平安好醫生(01833)今日公佈業績,上日股價走勢同樣先跌後回升,低位曾跌2.8%至93.65元,收市倒升約1%,報97.35元,逼近100天線。平安好醫生近日公佈旗下「平安好醫生」App更名為「平安健康」,以體現公司戰略全面升級、聚焦「醫療+健康」。股份今早升逾4%,升穿100元關口,高見102.2元。昨有逾60萬元淨流入其好倉,淡倉同日則有逾10萬元淨流出。

春節臨近,內地各省市陸續出台就地過年倡議,市場憧憬遊戲上線時間增加。網易(09999)昨以全日高位182.1元收市,漲2.19%,重越10天線並終止四連跌走勢。今早繼續做好,曾升逾3%,迫近189元。上日有約720萬元淨流入其好倉,淡倉同日則有逾10萬元淨流出。

瑞通相關認股證之選擇:

美團貼價、中短期購20119,行使價:419元,2021年5月到期,實際槓桿:4.6倍

美團輕微價外、中年期沽25499,行使價:369元,2021年8月到期,實際槓桿:3倍

平保輕微價外、中短期購12998,行使價:97.8元,2021年7月到期,實際槓桿:8.8倍

平保輕微價外、中短期沽19664,行使價:82.1元,2021年6月到期,實際槓桿:7.8倍

平醫價內、中短期購21295,行使價:100.98元,2021年6月到期,實際槓桿:4.6倍

網易輕微價外、中年期購11976,行使價:208.88元,2021年8月到期,實際槓桿:4.4倍

騰訊輕微價外、中短期購20146,行使價:785.38元,2021年6月到期,實際槓桿:5.3倍

騰訊價外、中年期沽24074,行使價:628.88元,2021年8月到期,實際槓桿:5倍

比迪價外、中短期購29333,行使價:318.88元,2021年7月到期,實際槓桿:3.4倍

瑞通相關牛熊證之選擇:

恆指牛證69485,收回價:28810點,槓桿比率:48.1倍

恆指熊證55685,收回價:29790點,槓桿比率:43.8倍

美團牛證69514,收回價:354.18元,槓桿比率:7.5倍

美團熊證59823,收回價:422.88元,槓桿比率:12.9倍

平保牛證60008,收回價:85.38元,槓桿比率:13.4倍

平保熊證61264,收回價:101.88元,槓桿比率:6.8倍

網易牛證56029,收回價:175元,槓桿比率:11倍

網易熊證55974,收回價:203元,槓桿比率:8.5倍

騰訊牛證69500,收回價:698.48元,槓桿比率:13.2倍

騰訊熊證58951,收回價:768元,槓桿比率:19.8倍

比迪牛證69798,收回價:234.88元,槓桿比率:7.7倍

比迪熊證52630,收回價:282.88元,槓桿比率:6.8倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account